WVE
Wave Life Sciences Ltd.Company with tickers: WVE
CIK
1631574
CUSIP
Y95308105
Shares Outstanding
192,402,202
13F Activity (30d)
154 filings
152 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-04-09 | Wright Christopher I |
Chief Medical Officer | Other | 45,625 |
| 2026-04-09 | Ingelsson Erik |
Chief Scientific Officer | Other | 0 |
| 2026-04-09 | Ingelsson Erik |
Chief Scientific Officer | Other | 87,864 |
| 2026-04-09 | Wright Christopher I |
Chief Medical Officer | Other | 0 |
| 2026-04-09 | Ingelsson Erik |
Chief Scientific Officer | Other | 0 |
| 2026-04-09 | Ingelsson Erik |
Chief Scientific Officer | Other | 0 |
| 2026-04-09 | Wright Christopher I |
Chief Medical Officer | Other | 0 |
| 2026-03-30 | RA CAPITAL MANAGEMENT, L.P. |
Director | Buy | 971,091 |
| 2026-03-27 | RA CAPITAL MANAGEMENT, L.P. |
Director | Buy | 2,495,623 |
| 2026-03-26 | RA CAPITAL MANAGEMENT, L.P. |
Director | Other | 28,815 |
| 2026-03-26 | RA CAPITAL MANAGEMENT, L.P. |
Director | Buy | 351,224 |
| 2026-03-26 | RA CAPITAL MANAGEMENT, L.P. |
Director | Buy | 4,954,558 |
| 2026-03-23 | TAKANASHI KEN |
Director | Other | 23,943 |
| 2026-03-23 | TAKANASHI KEN |
Director | Other | 3,901,348 |
| 2026-03-23 | TAKANASHI KEN |
Director | Other | 3,901,348 |
| 2026-02-26 | Francis Chris |
See Remarks | Convert | 17,900 |
| 2026-02-26 | Francis Chris |
See Remarks | Sell | 15,294 |
| 2026-02-26 | Francis Chris |
See Remarks | Convert | 15,294 |
| 2026-02-26 | Francis Chris |
See Remarks | Convert | 17,900 |
| 2026-02-26 | Francis Chris |
See Remarks | Convert | 15,294 |
| 2026-02-26 | Francis Chris |
See Remarks | Sell | 17,900 |
| 2026-02-09 | Francis Chris |
See Remarks | Sell | 1,883 |
| 2026-02-09 | Moran Kyle |
Chief Financial Officer | Sell | 3,588 |
| 2026-02-09 | Vargeese Chandra |
See Remarks | Sell | 3,228 |
| 2026-02-09 | BOLNO PAUL |
Director, President and CEO | Sell | 10,480 |
| 2026-02-05 | BOLNO PAUL |
Director, President and CEO | Award | 1,000,000 |
| 2026-02-05 | Moran Kyle |
Chief Financial Officer | Award | 273,750 |
| 2026-02-05 | Francis Chris |
See Remarks | Award | 38,750 |
| 2026-02-05 | Moran Kyle |
Chief Financial Officer | Award | 45,625 |
| 2026-02-05 | BOLNO PAUL |
Director, President and CEO | Award | 165,000 |
| 2026-02-05 | Vargeese Chandra |
See Remarks | Award | 45,625 |
| 2026-02-05 | Francis Chris |
See Remarks | Award | 232,500 |
| 2026-02-05 | Vargeese Chandra |
See Remarks | Award | 273,750 |
| 2026-01-02 | Francis Chris |
See Remarks | Convert | 9,375 |
| 2026-01-02 | Francis Chris |
See Remarks | Sell | 8,080 |
| 2026-01-02 | Francis Chris |
See Remarks | Convert | 9,375 |
| 2026-01-02 | Francis Chris |
See Remarks | Sell | 1,295 |
| 2025-12-11 | GLAXOSMITHKLINE PLC |
10% Owner | Buy | 1,470,000 |
| 2025-12-09 | Moran Kyle |
Chief Financial Officer | Sell | 36 |
| 2025-12-09 | Moran Kyle |
Chief Financial Officer | Convert | 50,000 |
| 2025-12-09 | Moran Kyle |
Chief Financial Officer | Convert | 36,000 |
| 2025-12-09 | Moran Kyle |
Chief Financial Officer | Award | 36,000 |
| 2025-12-09 | Moran Kyle |
Chief Financial Officer | Sell | 50,000 |
| 2025-12-09 | Moran Kyle |
Chief Financial Officer | Award | 50,000 |
| 2025-12-08 | Francis Chris |
See Remarks | Convert | 22,500 |
| 2025-12-08 | HENRY CHRISTIAN O |
Director | Convert | 30,000 |
| 2025-12-08 | HENRY CHRISTIAN O |
Director | Convert | 15,000 |
| 2025-12-08 | Moran Kyle |
Chief Financial Officer | Award | 50,000 |
| 2025-12-08 | Moran Kyle |
Chief Financial Officer | Sell | 50,000 |
| 2025-12-08 | Francis Chris |
See Remarks | Sell | 28,125 |
Showing 1–50 of 337 transactions